Old Web
English
Sign In
Acemap
>
authorDetail
>
Jason Howe
Jason Howe
Merck & Co.
Immunology
Internal medicine
Medicine
Vorinostat
Bortezomib
2
Papers
50
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vantage 095: Vorinostat in Combination with Bortezomib in Salvage Multiple Myeloma Patients: Final Study Results of a Global Phase 2b Trial
2011
Blood
David S. Siegel
Meletios A. Dimopoulos
Sung-Soo Yoon
Jacob P. Laubach
Jonathan L. Kaufman
Hartmut Goldschmidt
Donna E. Reece
Xavier Leleu
Simon Durrant
Fritz Offner
Michele Cavo
Arnon Nagler
Sundar Jagannath
Thorsten Graef
Jennifer Houp
Linda Sun
Jason Howe
Sandra Wear
Kenneth C. Anderson
Show All
Source
Cite
Save
Citations (37)
Combined Vorinostat, Lenalidomide and Dexamethasone Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase I Study.
2009
Blood
David Siegel
Donna M. Weber
Constantine S. Mitsiades
Meletios A. Dimopoulos
Jean-Luc Harousseau
Syed Rizvi
Jason Howe
David Reiser
Catriona Byrne
Kenneth C. Anderson
Paul G. Richardson
Show All
Source
Cite
Save
Citations (13)
1